155 related articles for article (PubMed ID: 20232213)
1. Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance.
Toki N; Kagami S; Kurita T; Kawagoe T; Matsuura Y; Hachisuga T; Matsuyama A; Hashimoto H; Izumi H; Kohno K
Virchows Arch; 2010 Apr; 456(4):387-93. PubMed ID: 20232213
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of BAF57 expression in patients with endometrial carcinoma.
Kagami S; Kurita T; Kawagoe T; Toki N; Matsuura Y; Hachisuga T; Matsuyama A; Hashimoto H; Izumi H; Kohno K
Histol Histopathol; 2012 May; 27(5):593-9. PubMed ID: 22419023
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial transcription factor a worsens the clinical course of patients with pancreatic cancer through inhibition of apoptosis of cancer cells.
Yamauchi M; Nakayama Y; Minagawa N; Torigoe T; Shibao K; Yamaguchi K
Pancreas; 2014 Apr; 43(3):405-10. PubMed ID: 24622070
[TBL] [Abstract][Full Text] [Related]
4. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2009 Apr; 22(4):522-9. PubMed ID: 19234438
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.
Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S
J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002
[TBL] [Abstract][Full Text] [Related]
7. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer.
Nakayama Y; Yamauchi M; Minagawa N; Torigoe T; Izumi H; Kohno K; Yamaguchi K
Oncol Rep; 2012 May; 27(5):1325-30. PubMed ID: 22266811
[TBL] [Abstract][Full Text] [Related]
9. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
11. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
[TBL] [Abstract][Full Text] [Related]
12. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
[TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53.
Brunner AH; Riss P; Heinze G; Meltzow E; Brustmann H
Int J Gynecol Pathol; 2011 Nov; 30(6):569-75. PubMed ID: 21979593
[TBL] [Abstract][Full Text] [Related]
14. Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus.
Ervine A; Leung S; Gilks CB; McCluggage WG
Histopathology; 2014 May; 64(6):840-6. PubMed ID: 24267480
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer.
Kurita T; Izumi H; Kagami S; Kawagoe T; Toki N; Matsuura Y; Hachisuga T; Kohno K
Cancer Sci; 2012 Feb; 103(2):239-444. PubMed ID: 22098591
[TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor.
Fujiwara S; Nawa A; Nakanishi T; Shimoyama Y; Kajiyama H; Shibata K; Ino K; Nakamura S; Kikkawa F; Yatabe Y
Hum Pathol; 2010 Apr; 41(4):560-5. PubMed ID: 20004952
[TBL] [Abstract][Full Text] [Related]
17. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
Guo ZL; Chen K; Wang XQ; Hu W
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
19. The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma.
Kimura T; Kitada S; Uramoto H; Zhi L; Kawatsu Y; Takeda T; Horie S; Nabeshima A; Noguchi H; Sasaguri Y; Izumi H; Kohno K; Yamada S
Histol Histopathol; 2015 Feb; 30(2):193-204. PubMed ID: 25108120
[TBL] [Abstract][Full Text] [Related]
20. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
Nakayama K; Rahman MT; Rahman M; Nakamura K; Ishikawa M; Katagiri H; Sato E; Ishibashi T; Iida K; Ishikawa N; Kyo S
Int J Oncol; 2016 Feb; 48(2):506-16. PubMed ID: 26647729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]